Syndax Pharmaceuticals Inc
SNDX· Nasdaq
SNDXSyndax Pharmaceuticals Inc
Filed May 9, 2017 · 10-Q · 39 days after period end · 0001193125-17-163872
| Metric | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|
| Revenue | $305.00K | $305.00K | — |
| Net Income | -$12.97M | -$10.33M | -$4.91M |
| EPS Diluted | -$2.85 | -$2.85 | -$206.30 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Syndax Pharmaceuticals Inc · CIK 1395937 · Engraved from SEC EDGAR
ended Mar 31, 2017 · filed May 9, 2017 · 39 d after period end
